Insider Transactions in Q4 2024 at Ocular Therapeutix, Inc (OCUL)

OCUL Quotes by TradingView

Insider Transaction List (Q4 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Oct 07 2024
Todd Anderman Chief Legal Officer
BUY
Grant, award, or other acquisition
Direct
98,700 +50.0%
-
Oct 02 2024
Jeffrey S. Heier Chief Scientific Officer
BUY
Grant, award, or other acquisition
Direct
100,000 +26.88%
-
Oct 02 2024
Peter Kaiser Chief Development Officer
BUY
Grant, award, or other acquisition
Direct
100,000 +31.65%
-

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL